BIO(Bio-Rad Laboratories, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $2.92B | $2.80B | $2.67B | $2.57B | $2.58B |
| 毛利润 | $1.64B | $1.57B | $1.43B | $1.38B | $1.34B |
| 营业利润 | $500.34M | $482.60M | $337.80M | $269.00M | $47.20M |
| 净利润 | $4.25B | −$3.63B | −$637.30M | −$1.84B | $759.90M |
| 经营现金流 | $669.46M | $194.40M | $374.90M | $455.20M | $532.20M |
| 自由现金流 | $535.72M | $81.60M | $218.20M | $289.60M | $374.60M |
| 摊薄每股收益 | $140.83 | $-121.79 | $-21.82 | $-65.36 | $27.85 |